Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

15.30
-0.6200-3.89%
Volume:478.82K
Turnover:7.51M
Market Cap:1.78B
PE:-11.70
High:16.24
Open:16.24
Low:15.07
Close:15.92
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:0.86
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.27
PE(LYR):-12.52

Loading ...

Novocure Limited : H.c. Wainwright Cuts Target Price to $46 From $48

THOMSON REUTERS
·
Jun 18

Novocure falls -18.2%

TIPRANKS
·
Jun 18

BUZZ-U.S. STOCKS ON THE MOVE-Pfizer, Accenture, Kroger

Reuters
·
Jun 18

Novocure's Late-Stage Trial For Tumor Treatment Misses Primary Endpoint

Dow Jones
·
Jun 18

Top Premarket Decliners

MT Newswires Live
·
Jun 18

NovoCure Phase 3 Glioblastoma Trial Misses Overall Survival Endpoint

MT Newswires Live
·
Jun 18

Novocure says Phase 3 TRIDENT trial did not meet primary endpoint

TIPRANKS
·
Jun 18

Novocure's cancer treatment fails to meet late-stage trial goal

Reuters
·
Jun 18

Novocure says Phase 3 TRIDENT glioblastoma trial misses overall survival endpoint for earlier TTFields use

Reuters
·
Jun 18

Novocure Announces Topline Data From the Phase 3 Trident Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma

THOMSON REUTERS
·
Jun 18

Novocure - Early Start Arm Median Overall Survival 17.7 Months VS 17.5 Months in Maintenance Start Arm

THOMSON REUTERS
·
Jun 18

Novocure - No New Safety Signals Observed in Trident Trial; Early Ttfields Initiation Feasible

THOMSON REUTERS
·
Jun 18

Novocure - Trident Trial Does Not Meet Primary Endpoint for Overall Survival

THOMSON REUTERS
·
Jun 18

NovoCure (NVCR) Appoints Frank Leonard To Its Board After Shareholder Vote

Simply Wall St.
·
Jun 17

Have Insiders Sold NovoCure Shares Recently?

Simply Wall St.
·
Jun 07

NovoCure Shareholders Approve Directors, Auditor and Incentive Plan

TIPRANKS
·
Jun 06

A Look At NovoCure (NVCR) Valuation As Shares Show Mixed Recent Performance

Simply Wall St.
·
Jun 02

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Novocure Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 05

Novocure price target raised to $17 from $13.50 at Wells Fargo

TIPRANKS
·
May 04